EUVIMEDEUVIMED entdecken
Open Access

Brain Derived Neurotrophic Factor as a Non-invasive Biomarker for Detection of Endometriosis

Sri Ratna Dwiningsih, Christina Meilani, Samsul Hadi

Journal of Reproduction & Infertility · 11.07.2022

DOI: 10.18502/jri.v23i3.10012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Reproduction & Infertility, online erschienen am 11.07.2022. Verfasst von Sri Ratna Dwiningsih und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Faculty of Medicine, Airlangga University, East Java, Indonesia. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Endometriosis is an estrogen-dependent chronic progressive gynecological dis-ease that affects around 10% of women of reproductive age. A recent study shows that brain-derived neurotrophic factor (BDNF) has the potential as a clinical marker in the diagnosis of endometriosis. We aimed to determine whether BDNF levels are correlated with pain scores associated with endometriosis.

Methods

Fifty women who underwent laparoscopy surgery at Dr. Soetomo General Hos-pital and Dr. Ramelan Navy Hospital were prospectively recruited from October 2017 until August 2018. A blood sample was obtained before surgery and BDNF was measured using the Human BDNF Quantakine®️ kit. The relationship of BDNF levels in serum with the diseases's level of pain and stages was compared between cases and controls. BDNF validity as an endometriosis diagnosis biomarker was assessed using receiver operating characteristic (ROC) analysis.

Results

Serum concentrations of BDNF were significantly greater in women with endo-metriosis (30.42±7.41 pg/ml), compared to controls (25.66±3.30 pg/ml). Serum concentra-tions of BDNF were moderately correlated with the patient’s reported pain scores (r=0.44, p=0.01). Receiver operating characteristic curve analysis confirmed the potential of BDNF in the diagnosis of endometriosis. Using a cut-off value of 27.06 pg/ml, the sensitivity and specificity were reported to be 66.7% and 64.3%, respectively.

Conclusion

BDNF serum levels in endometriosis women are significantly higher than in women without the disorder. BDNF serum level seems to have low accuracy and predictive value as a diagnostic marker for endometriosis. However, there was a moderate relationship between BDNF serum level and the degree of pain.

Schlagwörter

Stichwörter der Autor:innen

Brain derived neurotrophic factorEndometriosisInfertility

Autor:innen und Institutionen

  • Department of Obstetrics and Gynaecology, Faculty of Medicine, Airlangga University, East Java, Indonesia.

Zitieren

APA

Dwiningsih, S. R., Meilani, C., & Hadi, S. (2022). Brain Derived Neurotrophic Factor as a Non-invasive Biomarker for Detection of Endometriosis. Journal of Reproduction & Infertility. https://doi.org/10.18502/jri.v23i3.10012

Vancouver

Dwiningsih SR, Meilani C, Hadi S. Brain Derived Neurotrophic Factor as a Non-invasive Biomarker for Detection of Endometriosis. Journal of Reproduction & Infertility. 2022. doi:10.18502/jri.v23i3.10012

BibTeX
@article{Dwiningsih2022,
  author = {Dwiningsih, Sri Ratna and Meilani, Christina and Hadi, Samsul},
  title = {Brain Derived Neurotrophic Factor as a Non-invasive Biomarker for Detection of Endometriosis},
  journal = {Journal of Reproduction & Infertility},
  year = {2022},
  doi = {10.18502/jri.v23i3.10012}
}
Kostenlos starten →